Efficacy of lapatinib monotherapy on occult breast cancer presenting with cutaneous metastases: A case report

The case of a 72-year-old female who identified a lymph node enlargement in the left axilla is reported in the present study. A lymph node biopsy revealed a metastatic adenocarcinoma of the axillary lymph node. Following various assessments, the patient was diagnosed with occult breast cancer and lymph node metastases, for which treatment was initiated. Trastuzumab monotherapy was administered as the patient was elderly, positive for the hepatitis B virus and exhibited the following immunostaining/immunohistochemical analysis results: Estrogen receptor (ER) negative (-), progesterone receptor (PgR) negative (-) and human epidermal growth factor receptor 2 (HER2) positive (3+). Breast ultrasonography was performed 10 months after the initial trastuzumab administration and the left axillary lymph node enlargement had reduced in size and severity. However, a skin rash (erythema) was observed encompassing the left breast and extending into the axilla. As determined by the result of a skin biopsy of this area, the patient was diagnosed with occult breast cancer with cutaneous metastases. The immunohistochemical analysis results obtained from the skin biopsy were similar to those obtained from the lymph nodes: ER (-), PgR (-) and HER2 (3+). Therefore, the patient was switched from trastuzumab to lapatinib monotherapy. The erythema completely disappeared after two months of treatment. At present (34 months following lapatinib monotherapy initiation) no new lesions or severe side‑effects have been observed.

Invasive Breast Cancer in: Journal of the National Comprehensive

How safe is it to administer dual anti-HER2 block with pertuzumab

Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

PDF) Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

PDF) Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?

Case Report: Significant Efficacy of Pyrotinib in the Treatment of

Breast Cancer

Eiichiro NOGUCHI, Tokyo Women's Medical University, Tokyo, Department of Surgery II

PDF) Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

Mechanistic insights expatiating the biological role and

PDF) Recurrent Her-2 positive occult breast cancer presenting with zosteriform cutaneous metastases: a case report

Abstract Breast Cancer Research and Treatment

20745 PDFs Review articles in ERYTHEMA

Boob rash? What is this?

Freaked out by rash (picture included) - May 2020 Babies

EBF and weird rash on underside of breast **pic included

Efficacy of lapatinib monotherapy on occult breast cancer

Small, non itchy rash thing on left breast *pic included